Galectin Therapeutics Inc.
Galectin Therapeutics Inc. (GALT) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
galt · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Galectin Therapeutics Inc. (GALT) has a market cap — also referred to as its net worth or valuation — of $156,080,848, making it one of the top most valuable companies globally. Market Cap = $2.37 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Galectin Therapeutics Inc. (GALT) has a market cap — also referred to as its net worth or valuation — of $156,080,848 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Galectin Therapeutics Inc. reached its all-time high market cap of $730,209,065.316 on Dec 15, 2025. Comparing the Galectin Therapeutics Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Galectin Therapeutics Inc. net worth vs peers and ask how Galectin Therapeutics Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
GALT market cap · 6 questionsGalectin Therapeutics Inc.'s net worth — measured as market capitalization — is $156,080,848 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$2.37 (price) × shares outstanding.